Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee backs time‑limited psychedelic research bill focused on veterans with treatment‑resistant PTSD
Summary
HB390 (first substitute) would authorize a tightly scoped, legislatively overseen research trial on psychedelic‑assisted therapy for veterans with treatment‑resistant PTSD, including a proposed $2 million budget and oversight by FDA/DEA and the University of Utah IRB; the committee adopted a substitute and advanced the bill unanimously.
Representative Daley-Provo (presenting HB390) described the bill as a carefully designed, limited research trial to generate Utah‑specific safety and outcomes data for psychedelic‑assisted therapies for veterans with treatment‑resistant PTSD. She framed the proposal as…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
